Bio-Rad Laboratories Key Ratios

Stock Card

$379.50

$0.00 (0.00%)

As on 05-Nov-2026 09:30EST

Market cap

$10,147 Mln

Revenue (TTM)

$2,593 Mln

P/E Ratio

10.1

P/B Ratio

1.4

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	0.83	0.52	1.38	-1.59	-2.74
EBIT	-0.58	231.57	272.53	128.23	-30.69
Net Profit	23.48	234.13	251.34	105.37	-31.25
EPS	22.88	234.02	256.24	105.73	-29.66
Book Value	--	--	17.60	-5.09	-3.37

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	TTM	Dec-25	Dec-24
EBIT-Margin	-26.30	-11.78	52.80	40.43	-89.37
Net Margin	--	8.48	39.45	--	--
Return on equity	-6.73	-3.05	14.15	10.84	-24.09
Return on Capital	-5.81	-2.23	--	8.98	-20.39
Return on Assets	-4.78	-1.97	9.31	7.62	-17.03
Debt to Equity (x)	--	--	0.11	0.21	0.21

Profitability

View Detailed Peer Comparison

ROCE

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	--	8.98	-20.39	-6.03	-29.12	35.43
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROE

14.15

Higher than Peers by 8.18

Profit after tax / Average Net worth * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	14.15	10.84	-24.09	-6.94	-31.14	36.11
Peer Median	5.98	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROA

9.31

Higher than Peers by 6.45

Profit after tax / Average Total assets * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	9.31	7.62	-17.03	-4.94	-23.18	27.65
Peer Median	2.86	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EBIT Margin

52.80

Higher than Peers by 42.72

Operating profit (EBIT) / Net Sales * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	52.80	40.43	-89.37	-29.97	-166.51	186.50
Peer Median	10.09	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Margin

39.45

Higher than Peers by 33.04

Net profit / Total Income (Net sales plus other income) * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	39.45	29.42	-71.86	-23.86	-127.41	144.38
Peer Median	6.42	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Cash Profit Margin

(Net profit + Depreciation) / Gross Sales * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	--	--	--	--	--	--
Peer Median	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

1.38

Lower than Peers by 7.75

Year on year growth in net sales

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	1.38	0.01	-0.04	-0.05	-0.04	0.15
Peer Median	9.12	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EBIT Growth

272.53

Higher than Peers by 259.76

Year on year growth in operating profit (EBIT)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	272.53	145.54	-186.45	82.84	-185.61	10.34
Peer Median	12.76	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Profit Growth

251.34

Higher than Peers by 237.31

Year on year growth in profit after tax

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	251.34	141.20	-189.37	82.43	-185.27	11.54
Peer Median	14.03	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EPS Growth

256.24

Higher than Peers by 234.64

Year on year growth in earnings per share

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	256.24	1.43	-1.98	0.82	-1.86	0.12
Peer Median	21.60	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Book Value Growth

12.77

Higher than Peers by 4.86

Year on year growth in book value per share

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	12.77	--	--	--	--	--
Peer Median	7.90	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.11

Lower than Peers by 0.24

Total debt / Net worth

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	0.11	0.21	0.21	0.16	0.14	0.02
Peer Median	0.35	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Short term debt to equity ratio

0.06

(Short term borrowings / Net worth)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	0.06	0.01	0.01	0.00	0.00	0.00
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Current Ratio

3.18

Higher than Peers by 0.32

Current Assets / Current Liabilities and Provisions

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	3.18	5.62	6.48	5.83	5.55	2.92
Peer Median	2.85	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Quick Ratio

2.37

Higher than Peers by 0.28

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	2.37	4.19	4.85	4.34	4.29	2.08
Peer Median	2.09	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Interest Coverage

28.05

Higher than Peers by 22.48

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	28.05	21.32	-46.90	-16.20	-122.43	3,514.25
Peer Median	5.57	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

16.30

Lower than Peers by 0.10

Debtors outstanding / Net Sales * 100

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	16.30	18.29	17.63	18.31	17.65	14.49
Peer Median	16.40	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Asset Turnover

0.24

Lower than Peers by 0.26

Sales / Average Total Assets

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	0.24	0.26	0.24	0.21	0.18	0.19
Peer Median	0.50	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Receivable days

Average Debtors / Sales * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	--	65.39	66.99	67.25	59.84	52.68
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Inventory Days

Average Inventory / Sales * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	--	221.09	236.89	220.12	191.00	169.83
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Payable days

Average Creditors / Cost of goods sold * 365

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	--	37.02	41.04	41.04	40.96	40.01
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Cash Conversion Cycle

Receivable Days + Inventory Days - Payable Days

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	--	249.46	262.84	246.33	209.88	182.50
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

10.08

Lower than Peers by 33.97

Current share price divided by earning per share in the last twelve months

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	10.08	--	-4.94	-14.50	-3.32	5.08
Peer Median	44.05	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Price / Book Value

1.41

Lower than Peers by 3.04

Current share price divided by book value per share in the latest financial year

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	1.41	--	1.39	1.06	1.25	1.58
Peer Median	4.45	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Dividend Yield

Dividend per share in the past twelve months divided by current share price

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	--	--	--	--	--	--
Peer Median	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EV/EBITDA

17.45

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	17.45	--	-4.12	-13.80	-2.57	3.76
Peer Median

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Market Cap

10,147

Higher than Peers by 9,502

Current Share price multiplied by latest total number of shares outstanding

Company Name	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Bio-Rad Laboratories	10,147	--	--	--	--	--
Peer Median	645	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly